TrialBritish journal of pharmacology2019

Neprilysin inhibition for pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled, proof-of-concept trial.

Adrian J Hobbs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.